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Abstract
Introduction: HIV self-testing (HIVST) is a discreet and convenient way to reach people with HIV who do not know their
status, including many who may not otherwise test. To inform World Health Organization (WHO) guidance, we assessed the
effect of HIVST on uptake and frequency of testing, as well as identification of HIV-positive persons, linkage to care, social
harm, and risk behaviour.
Methods: We systematically searched for studies comparing HIVST to standard HIV testing until 1 June 2016. Meta-analyses
of studies reporting comparable outcomes were conducted using a random-effects model for relative risks (RR) and 95%
confidence intervals. The quality of evidence was evaluated using GRADE.
Results: After screening 638 citations, we identified five randomized controlled trials (RCTs) comparing HIVST to standard
HIV testing services among 4,145 total participants from four countries. All offered free oral-fluid rapid tests for HIVST and
were among men. Meta-analysis of three RCTs showed HIVST doubled uptake of testing among men (RR = 2.12; 95% CI: 1.51,
2.98). Meta-analysis of two RCTs among men who have sex with men showed frequency of testing nearly doubled (Rate
ratio = 1.88; 95% CI: 1.17; 3.01), resulting in two more tests in a 12–15-month period (Mean difference = 2.13; 95% CI: 1.59,
2.66). Meta-analysis of two RCTs showed HIVST also doubled the likelihood of an HIV-positive diagnosis (RR = 2.02; 95% CI:
0.37, 10.76, 5.32). Across all RCTs, there was no indication of harm attributable to HIVST and potential increases in risk-taking
behaviour appeared to be minimal.
Conclusions: HIVST is associated with increased uptake and frequency of testing in RCTs. Such increases, particularly among
those at risk who may not otherwise test, will likely identify more HIV-positive individuals as compared to standard testing
services alone. However, further research on how to support linkage to confirmatory testing, prevention, treatment and care
services is needed. WHO now recommends HIVST as an additional HIV testing approach.
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Introduction
Global scale-up of HIV testing services (HTS) has been signifi-
cant. From 2010 to 2014, more than 600 million people
received HTS in 122 low- and middle-income countries [1].
This expansion has been made possible through the wide-
spread introduction of provider-initiated testing and counsel-
ling and an array of community-based approaches which are
now considered the standard of care [2]. Despite this, approxi-
mately 40% of all HIV infections are undiagnosed worldwide
[3] and countries are seeking ways to increase the number of
people who know their HIV status to achieve the first of the
United Nation’s 90-90-90 HIV testing and treatment goals –
diagnosis of 90% of all people with HIV by 2020 [4].
HIV self-testing (HIVST) has been proposed as an
approach to reach people who are not accessing existing
HTS, such as men, young people, and key populations (i.e.
people who inject drugs, men who have sex with men, sex
workers, and transgender people). HIVST refers specifically
to a process in which a person collects his or her specimen
(oral fluid or blood) and performs a test and interprets the
result, often in private or with someone they trust [2].
Several observational studies [5–17] and systematic
reviews [18–21] have shown HIVST can be performed accu-
rately and is an acceptable and feasible testing approach in
a variety of contexts; including among populations at
ongoing HIV risk and those who may not otherwise test.
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As a discreet, convenient and empowering approach, many
well-documented barriers to standard HTS, such as long-
lines, services offered at inconvenient times, fear of stigma
and lack of confidentiality [22], can be addressed by HIVST
[18,23–26].
To assess the potential effects of HIVST compared to stan-
dard HTS, that is, facility- or community-based approaches, we
conducted a systematic review. Our objective was to assess
the effects of HIVST on uptake and frequency of HIV testing,
diagnosis of people with HIV, linkage to prevention and care,
risk behaviour, social harm or other adverse events, compared
to standard HTS. Review findings were then used to help
determine whether HIVST should be recommended as an
additional HTS approach in WHO guidelines.
Methods
This review followed guidance from the Cochrane
Collaboration [27] and the PRISMA statement for the report-
ing of systematic reviews and meta-analyses. The review pro-
tocol and the full quality assessment are available in Appendix
1–2 (Supplemental material).
Search strategy and inclusion criteria
We searched five electronic databases PubMed, CINAHL,
PsycINFO, Sociological Abstracts, and EMBASE through 1
June 2016 for peer-reviewed articles. We also searched
the following conference databases for abstracts:
International AIDS Conference (IAC), International AIDS
Society Conference on HIV Pathogenesis, Treatment, and
Prevention (IAS), and Conference on Retroviruses and
Opportunistic Infections (CROI). IAC and IAS conference
abstracts were searched for all available years (2001–
2015). For CROI, only recent conferences (2014–2016)
were searched as past conferences were inaccessible.
Secondary reference searching was conducted on all stu-
dies included in the review as well as on previously pub-
lished reviews. We also contacted experts to identify
additional studies, specifically abstracts being presented at
the 2016 IAC, and reviewed databases listing ongoing RCTs
through clinicaltrials.gov, WHO International Clinical Trials
Registry Platform, and Pan African Clinical Trials Registry.
The search strategy was adapted for entry into all compu-
ter databases using key terms “HIV”, “self-test”, and “home
test” (Appendix 1 (Supplemental material)). To search HIV-
related conference abstracts, only terms for self-testing were
used because search functions were limited. No language or
geographic limitations were placed on the search.
Two reviewers (CK and VF) screened studies. The first
reviewer identified study titles and abstracts meeting the
inclusion criteria. The second reviewer evaluated the appli-
cation of screening criteria and approved selected studies.
Disagreements between reviewers were resolved through
discussion and consensus. CJ, VF, CK also contacted all
authors of studies included in the review to collect addi-
tional information about each study.
To be included, studies needed to directly compare
HIVST to HTS by a provider in either a facility or community
setting (defined as standard HTS) and report on one or
more of the following outcomes: (1) uptake of HIV testing
(e.g. the number of participants who tested for HIV in the
study period); (2) frequency of HIV testing (e.g. the number
of times a participant tested for HIV in the study period);
(3) social harm/adverse events (defined as any undesirable
experience, or intended or unintended harm associated
with HIV self-testing); (4) HIV positivity (e.g. the proportion
of people with a reactive self-test who received confirma-
tory HTS and were diagnosed HIV positive); (5) proportion
of people linked to confirmatory testing, clinical assessment
or treatment and/or measurement of CD4 or viral load
among those diagnosed HIV positive; (6) linkage to preven-
tion services following nonreactive self-test result; or (7)
sexual risk behaviour (measured as report of condomless
sex, sexual transmitted infections (STIs) or number of sexual
partners).
Additionally, we also searched for the full-text publica-
tion of any abstract included in the review as of 15 March
2017 to check for updates to previous reports.
Data analysis
Data were extracted independently by four reviewers using
standardized extraction forms. Risk of bias was assessed
according to guidance by the Cochrane Collaboration and
determined by CK, VF, NS, and CJ [27]. Where multiple
studies reported the same or comparable outcomes,
meta-analyses were conducted using random-effects mod-
els to combine relative risks for dichotomous data, mean
differences for continuous data, or rate ratios for frequency
data, with 95% confidence intervals using REVMAN 5.3.5.
Quality assessment
GRADE methodology was used to assess and appraise the
quality of evidence for each outcome across all studies, and
included an evaluation of the risk of bias, imprecision,
indirectness, and inconsistency, and other considerations
including publication bias [28] (Appendix 2 (Supplemental
material)).
Results
The searches yielded 638 citations, which after screening
resulted in five eligible RCTs (Figure 1).
Study characteristics
All five RCTs were published between 2015 and 2017. Three
were full-text manuscripts [29–31], one of which was in
press [31,32], and two were conference abstracts [33,34].
These studies included a total of 4,145 individuals (range:
230–2523). The largest study was among 1410 pregnant
women and 1113 of their locatable male partners in
Kenya [33]. All RCTs reported outcomes among men: two
took place in Kenya where women delivered HIVST to their
male partners [30,33] and the remainder were among men
who have sex with men (MSM) in Australia [29], Hong Kong
SAR [31,32], and the United States [34]. Table 1 summarizes
the study characteristics.
All studies offered free oral HIVST kits with the manu-
facturer’s instructions for use, but differed in terms of the
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number of kits and the level of assistance provided. In
order to encourage quarterly testing, in the United States
and Australia, MSM had continuous access to HIVST kits
[29,34], and in Australia, participants received four HIVST
kits at enrolment. In Kenya, women were provided with
two HIVST kits at enrolment (one for them and one for
their male partner) [30,33]. In Hong Kong SAR, MSM were
provided with only one HIVST kit at enrolment [31,32].
HIVST can be delivered with direct assistance, such as an
in-person demonstration on how to self-test, or unassisted
using either manufacture instructions for use alone. In addi-
tion, other support tools such as telephone hotlines, videos
or messaging services may also be provided [2]. Two RCTs
[29,31,32] provided unassisted HIVST, but in addition to the
test kit participants had access an informational video; and
one RCT, also provided motivational interviewing via tele-
phone and counselling through online live-chat services
[31,32]. The remainder provided an in-person demonstration
on how to self-test (direct assistance) [30,33,34]; two of
which provided women a demonstration so they could
show their male partners how to self-test [30,33].
Uptake of HIV testing
Three RCTs [30–33] reported on uptake of HIV testing
(Table 2). A meta-analysis showed moderate-quality evi-
dence that HIVST doubled the uptake of HIV testing com-
pared to standard HTS (RR = 2.12; 95% CI: 1.51, 2.98;
Tau2 = 0.08; Chi2 = 32.88, df = 2 (p = 0.001; I2 = 94%))
(Figure 2). The high level of statistical heterogeneity was
driven by the Gichangi and colleagues RCT [33], which
measured uptake among men who had accepted some
form of HIV testing and did not include those who declined
testing. Since the estimate of effects was beneficial for all
three RCTs, we did not downgrade for inconsistency. Two
RCTs [30,33], where women delivered HIVST to their male
partners, also reported HIVST increased uptake of couples
testing compared to standard HTS, with moderate-quality
evidence (Table 2).
There was low-quality evidence that HIVST resulted in
greater HIV testing uptake among young MSM in Hong Kong
SAR (18–25 years of age), including both recent and non-
recent testers compared to standard HTS (Young MSM:
RR = 1.79; 95% CI: 1.43, 2.24; Recent testers: RR = 1.75; 95%
CI: 1.46, 2.08; Non-recent testers: RR = 2.22; 95% CI: 1.61;
3.08) [31,32]. In this same study, MSMwho reported condom-
less anal intercourse at baseline were more likely to test if
they were in the HIVST group compared to if they were in the
standard testing group (RR = 1.75; 95% CI: 1.26, 1.81) [31,32].
Frequency of HIV testing
Two RCTs [29,34] in this review, both among MSM, reported
on the frequency of HIV testing. Meta-analysis showed there
was low-quality evidence that HIVST nearly doubled testing
frequency compared to facility-based testing (Rate
ratio = 1.88; 95% CI: 1.17; 3.01; Tau2 = 0.11, Chi2 = 23.33,
df = 1 (p < 0.0001), I2 = 96%) (Figure 3) and resulted in two
more HIV tests in a 12–15-month period than those receiving
standard facility-based HTS (Mean difference = 2.13; 95% CI:
1.59, 2.66; Tau2 = 0.10; Chi2 = 2.37, df = 1 (p = 0∙12),
I2 = 58%) (Figure 4) [29,34]. In Australia, there was very
low-quality evidence that HIVST substantially increased the
frequency of testing among non-recent testers compared to
standard facility-based HIV testing at 12 months (Rate
ratio = 5.54; 95% CI: 3.15, 9.74)[29] (Table 3).
HIV positivity
Two RCTs [30,34] reported on HIV positivity following HIV
testing. Meta-analysis showed there was very low-quality
evidence that HIVST doubled the likelihood of an
HIV-positive diagnosis compared to those using standard
Records identified 
through database 
searching (N=567)
Conference 
abstracts 
identified 
(N=52)
Records screened (N=496)
Records after duplicates removed (N=496)
Full-text articles assessed for 
eligibility (N=179)
Records excluded after first 
review (N=317)
Studies included in the GRADE 
review (N=5)
Full-text articles excluded 
(N=174) because: 
• Did not meet study 
inclusion criteria (N=172) 
• Duplicative (N=2) 
Additional records identified 
through other sources 
(N=19)
Figure 1. Study selection.
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testing alone (RR = 2.02; 95% CI: 0.37, 10.76, 5.32)
(Figure 5).
Linkage to care
One RCT in Kenya [30], with very low-quality evidence,
reported on linkage to care. In the study, women reported
that 25% (n = 2/8) of their male partners in the HIVST group
linked to confirmatory testing at 3-month follow-up.
Following confirmatory testing, both men were reportedly
confirmed HIV positive and then linked to care. In the
control group, women reported that all four male partners
who were diagnosed HIV positive linked to care.
Risk behaviour
Two RCTs [31,32,34] reported on risk-taking behaviours. In
the United States, there was very low-quality evidence
showing that MSM in the HIVST group did not increase
condomless anal intercourse compared to those under-
going facility-based HTS (RR = 0.94: 95% CI: 0.55, 1.61)
[34]. In this same study, there was very low-quality evi-
dence that men in the HIVST group acquired fewer STIs
than those in the standard HTS group (RR = 0.42; 95% CI:
1.15, 1.15) [34]. However, among MSM in Hong Kong SAR,
there was very low-quality evidence that those in the HIVST
group were more likely to report condomless anal inter-
course (RR = 1.43: 95% CI: 0.98, 2.08) at 6-month follow-up
than those in the standard HTS group.
Social harm
One RCT [30] with very low-quality evidence reported on
social harm following HIVST or standard facility-based HTS.
In this trial, there were reports of a single harm in each
group among two HIV-negative participants, 1/297 (0.34%)
in the HIVST group and 1/303 (0.33%) in the control group,
both relating to verbal and/or physical intimate-partner
violence (IPV). In the HIVST group, the harm was not
directly related to HIVST as the female participant reported
violence occurred as a result of agreeing to participate in
the study without consulting her husband. At enrolment
neither participant reported experiencing IPV in the past
12 months, and the RCT used IPV screening tools and
excluded women reporting risk of IPV [30].
Discussion
Standard HTS approaches are essential and serve many
people, but current approaches continue to miss a sub-
stantial number of people with HIV and those at high
ongoing risk. This systematic review and meta-analysis
finds there is moderate quality evidence that HIVST can
increase the uptake of HIV testing and low-quality evi-
dence that HIVST increases the frequency of HIV testing.
This evidence is limited to MSM and male partners of
pregnant and post-partum women in sub-Saharan Africa.
However, these findings on increased uptake are consis-
tent with the results of implementation studies from
Kenya [13,35], Lesotho [17], Malawi [36,37], and
Zimbabwe [38] which have been conducted among
other populations known to have poor testing coverage,Ta
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including men, young people and the households of peo-
ple newly diagnosed with HIV, but do not directly com-
pare with standard facility-based HTS.
Such increases in HIV testing uptake and frequency have
important public health implications, if they can be
achieved at a population level and reach those with undiag-
nosed HIV infection and at ongoing risk. As shown by two
RCTs in this review [30,34] and reports from several other
studies [12,15,31,36,39,40], increased testing due to HIVST
can identify a greater or equivalent proportion of HIV
infections as many existing HTS approaches. Sustained
increases in HIV testing among men and other higher-risk
populations, facilitated by HIVST, could identify a greater
number of infections, and at an early stage in their infec-
tion [41], and result in earlier diagnosis and initiation of
treatment and reduce HIV-related mortality. This is a parti-
cular priority for men, as they have greater HIV-related
mortality than their female peers [42].
Limited information on linkage to care was identified in
this review. Of the two RCTs reporting, one found that 72%
(n = 396) of the male partners of women who received an
HIVST kit said they accessed further testing to confirm their
result [33]. This outcome, however, could not be directly
compared with standard testing. In the other [30], while
linkage following a reactive self-test appeared lower than
those diagnosed in the standard group, few HIV-positive
test results (n = 8) were reported. Additionally, this low
level of linkage may be due to under-reporting and the
possibility that some men already knew their HIV-positive
status and were in care.
There are approaches following HIVST known to facilitate
linkage to treatment, such as the offer of home-based ART
initiation which resulted in a three-fold increase in linkage
to care following HIVST in Malawi [43]. While results from a
cluster-randomized trial in Malawi and a cohort study in
Kenya suggest linkage to care following HIVST can be com-
parable to current national linkage rates [15,36], efforts to
shorten the time between diagnosis and enrolment in care
and improve overall linkage rates are needed. Further
research is needed to identify ways to enhance linkage
following HIVST; particularly for key populations, who may
be less likely to link to services due to restrictive laws and
policies.
Results from three RCTs [29,31,32,34] reporting on risk
behaviours suggest HIVST did not increase risk-taking beha-
viour among MSM. While one RCT reported very low-quality
evidence that HIVST could increase and having multiple sex
partners among MSM in [31,32], results were not statistically
significant. Additionally, data collected at baseline suggested
high-risk MSM may be more likely to take up HIVST than
standard HTS; and a sub-analysis among MSM who took up
any testing across both arms found no effect on (RR = 0.81,
95% CI: 0.57, 1.75) and a minimal effect in reducing multiple
male sex partners (RR = 0.72, 95% CI > 0.54, 0.95) [31,32].
Thus, while HIVST may not directly increase risk behaviours,
there is some uncertainty and it is important that messages
which reinforce the importance of using effective HIV pre-
vention methods, such as condoms, are provided.
Only a single IPV event [30], which was not directly
related to HIVST, was identified in this review of RCTs.
Figure 2. Uptake of HIV testing over three and six month periods among male partners of pregnant women and men who have sex with
men.
Figure 3. Rate ratio of frequency of testing in a 12–15-month period among men who have sex with men.
Figure 4. Frequency of HIV testing measured by the mean number of tests in a 12–15-month period among men who have sex with men.
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Such findings are consistent with those reported by a
review assessing harm resulting from self-testing for various
conditions and diseases [44], an observational study in the
United States among MSM [45], and a 2-year cluster-ran-
domized trial [36] and parallel longitudinal qualitative study
[24,46] in Malawi, which reported no cases of physical
violence, self-harm or suicide and few cases of “coercion”.
In Malawi, the majority of those reporting “coercion”
were men who also stated they were highly satisfied with
HIVST (92%, 130/141) and would recommend it to others
[36]. Qualitative findings from this same study also indi-
cated that most users consider HIVST to be empowering,
but some couples (n = 2/17) felt “pressure” to self-test by
their partner and said serodiscordant HIVST results were
challenging [24,46]. In contrast, a cohort study among 265
HIV-negative pregnant and post-partum women and female
sex workers in Kenya reported two cases of IPV among
post-partum women who distributed HIVST to their male
partner and two cases of physical violence among female
sex workers who distributed HIVST to their clients [15]. It is
unclear if these cases were attributable to HIVST, as 41% of
women in the study reported experiencing violence in the
preceding 12 months [15]. These findings suggest that not
all testing approaches are appropriate for all contexts, and
caution is still needed in vulnerable populations. In order to
guide safe HIVST implementation, programmes will need to
consult populations at a risk of abuse. Additionally, HIVST
may not be an appropriate or safe approach for all popula-
tions. It is important that information on where and how to
access other HTS approaches, including community-based
options, continues to be provided.
Strengths and limitations
While other reviews on HIVST have assessed accuracy,
feasibility and acceptability [18–21], this review is the first
to directly compare HIVST to standard HTS and to system-
atically assess the effect of HIVST on uptake and frequency
of testing, diagnosis of HIV-positive persons, linkage to care,
risk behaviour and potential social harm. Additional
strengths of this review include its ability to identify the
latest evidence in both published and grey literature, its
adherence to the PRISMA and Cochrane reporting stan-
dards and its consultation with global experts when defin-
ing the outcomes of interest to ensure finding would be
relevant to the implementation and delivery of HTS
(Appendix 2 (Supplemental material)).
The review and RCTs included, however, also have sev-
eral limitations. Few studies which directly compared HIVST
to standard HTS were identified in the review, and meta-
analyses were only able to be performed among a small
number of RCTs which had comparable outcomes. RCTs
identified focused on male partners of women in antenatal
or post-partum care and MSM, including sub-groups of
recent and non-recent testers and young MSM. Other
populations were not evaluated.
All RCTs compared HIVST to facility-based HTS. None
compared HIVST to other community-based HTS
approaches. Testing behaviour was assessed through self-
report in all five RCTs and the potential for detection biasTa
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cannot be disregarded. However, self-reported data was
validated with clinical records in two RCTs [29,32]. Two
studies in this review were conference abstracts.
However, we were able to contact all authors directly and
obtain additional information, including full study protocols,
which addressed some reporting gaps (Appendix 2
(Supplemental material)).
Conclusions
This review found greater uptake of and frequency of HIV
testing associated with HIVST compared to standard HTS.
Risk-taking behaviour did not appear to increase due to
HIVST, nor was HIVST associated with harm. Based on the
findings of this review, and additional information reviewed
at an expert meeting, WHO now recommends HIVST be
offered as an additional HTS approach. Countries should
make HIVST available and determine how to use this
approach to fill gaps in testing coverage and reach those
at risk who are not accessing existing HTS. Further assess-
ment of different service delivery models and strategies to
facilitate linkage, cost-effectiveness and the pathway to
create supportive policies will be needed to maximize the
potential of introducing HIVST.
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